SkinHealth Systems Inc.
SKIN | NASDAQ
$0.68
+$0.01 (+0.74%)
At close: Sep 21, 2026, 4:00 PM ET
$0.68
-$0.01 (-0.74%)
After-hours:
Sep 21, 2026, 4:10 PM ET
Market Data
Market Cap $87.48M
Enterprise Value $248.48M
Beta 1.00
Average Volume 2.07M
Shares Outstanding (Diluted) 129.6M
Shares Change YoY -7.62%
Institutional Ownership 61.24%
Exchange NASDAQ
ISIN US88331L1089
Price Performance
Price Change 1M 4.6%
Price Change 3M 2.0%
Price Change 6M -32.0%
Price Change YTD -51.4%
Price Change 1Y -70.2%
Price Change 3Y -88.4%
Price Change 5Y -97.5%
1M CAGR (ann.) -12.1%
1Y CAGR (ann.) -71.8%
5Y CAGR (ann.) -51.9%
All-Time CAGR -37.9%
Valuation
PE Ratio -3.09
Forward PE N/A
PEG Ratio 0.01
Forward PEG 0.04
PS Ratio 0.30
Forward PS 0.30
PB Ratio 1.57
P/FCF Ratio 6.70
P/Adj. FCF Ratio -3,124.29
P/OCF Ratio 4.00
EV/Sales 0.86
EV/EBIT 154.24
EV/EBITDA 8.60
EV/FCF 19.02
Earnings Yield -32.4%
FCF Yield 14.9%
Adj. FCF Yield 0.0%
Financial Health
Net Debt $161M
Total Debt $367.1M
Cash & Short-Term Investments $206.1M
Total Assets $486.6M
Current Ratio 1.76
Quick Ratio 1.48
Debt / Equity Ratio 6.60
Debt / EBITDA 12.71
Debt / FCF 28.10
OCF / Debt 0.04
Interest Coverage -0.17
Altman Z-Score -0.47
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 66.3%
Operating Profit Margin -1.5%
EBITDA Margin 10.0%
Net Profit Margin -9.8%
FCF Margin 4.5%
Adj. FCF Margin 0.0%
SBC / Revenue 3.8%
SBC Impact (per share) -100.2%
Returns
Return on Assets -5.8%
Return on Equity -47.8%
Return on Invested Capital -1.0%
Return on Capital Employed -1.4%
Return on Tangible Assets -8.6%
Historical Growth (CAGR)
Revenue CAGR 3Y -9.4%
Revenue CAGR 5Y 9.2%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 68.8%
EPS CAGR 5Y 40.6%
EPS CAGR 10Y N/A
FCF CAGR 3Y 69.5%
FCF CAGR 5Y 143.2%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Hold
Analyst Count 14
EPS Growth Next 3Y 34.8%
Revenue Growth Next 3Y 4.8%
Earnings Date N/A
EPS Estimate (next Q) N/A
EPS Growth Est (next Q) N/A
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $1.50
Price Target Upside 120.6%
Cash Flow
Operating Cash Flow $16.41M
Free Cash Flow $13.07M
Adj. Free Cash Flow $-28K
FCF Per Share $0.13
OCF Per Share $0.17
OCF/S Ratio 7.6%
Income Statement
Revenue $290.04M
Gross Profit $192.41M
Operating Income $-4.31M
EBITDA $28.89M
Net Income $-28.4M
EPS (Diluted) -$0.22
Revenue / Employee $473.14K
Profit / Employee $-46.34K
Employees 613
Add to Watchlist
Select watchlists to add or remove SKIN